1 Introduction Primary liver cancer (PLC) is the sixth most commonly diagnosed malignancy and the third leading cause of cancer-related death globally, with ~906,000 new cases and 830,000 deaths annually [1]. Hepatocellular carcinoma (HCC) constitutes 75%–85% of all PLC cases [2]. Due to the absence of obvious clinical symptoms in the early stages, most patients are diagnosed at an advanced stage, leading to a poor prognosis [3].
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile